Update on the Belgian Cancer Registry,
|
|
|
- Sydney Harvey
- 10 years ago
- Views:
Transcription
1 Update on the Belgian Cancer Registry, breast cancer data... Belgian Breast Meeting 3-4/10/2008 Liesbet Van Eycken
2 Overview Introduction, history of the BCR Breast Cancer Incidence - Mortality Europe Belgium Flanders
3 History cancer registration in Belgium 1955 Obligatory health insurance social disease 1983 NKR-RNC 1994 AKR/LIKAR 2002 CIV IACR Flemish Network KB MOC - KB normen onco basiszorg en progr 2005: -STOP NCR
4 Belgian Cancer Registry Founded 1/7/2005 Collaboration between physicians, autorities and health insurances 12/2006: Health Law, art. 39: Kankerregister- Registre du Cancer Autorisation to use the national number Description of data transfer and pathways Clinical pathway (moc non moc) Pathology and Hematology pathway Cancer Plan March 2008 All cancers MOC Data manager funding in the hospital...
5 Actual Data sources Belgian Cancer Registry Hospitals: Oncol Care MOC non-moc Pathology labs Haematology Health Insurances Belgian Cancer Registry
6 CANCER IN EUROPE, new cancer cases 53% males 47% females cancer deaths 56% males 44% females Ferlay J et al, Ann Onc 2007, doi: /annonc/mdl498
7 Cancer incidence and mortality, estimates 2006 EUROPE Incidence (n) Total: Mortality (n) Total: Breast: Colorectal: Lung: Prostate: Lung: Colorectal: Breast: Stomach: Ferlay J et al, Ann Onc 2007, doi: /annonc/mdl498
8 2004, Breast Cancer, Belgium: new cases Borstkanker in België, 2004 Absolute aantallen 1400 Aantallen / , ,0 400,0 350, ,0 250, , ,0 100,0 50, Leeftijdscategorie 0,0 Absolute aantallen Aantallen /
9 Breast Cancer, 2004 Belgium Flemish Region Walloon region Brussels region % 33% 10%
10 Breast Cancer, Age standardised incidence, 2004 breast Wallonië Brussel Vlaanderen ESR (n/100,000)
11 n/100,000 Breast cancer, 2004, Age specific incidence 700,0 600,0 500,0 400,0 300,0 Flemish Region Walloon Region Brussels Region 200,0 100,0 0, age
12 Reasons? Methodology? Check (Wall-Bxl) Administrative procedures? Prevalent cases? Result check: >3.000 cases: change of 2,2%! Influence screening programs (timing)? Risk factors? Next years?...
13
14 ESR (Aantallen / ) Breast Cancer: evolution of age stand. incidence rates Flemish Region Flanders: evolution of age standardised incidence rates (3 age categories) Jaar alle leeftijden
15
16
17
18
19
20
21 Flemish Region, Breast Cancer: evolution of incidence and mortality per age category <50 y 50-69y 70+ ESR (N/ ) Borstkanker in Vlaanderen, Leeftijdscategorie 0-49 Mortaliteit versus incidentie ESR (N/ ) Borstkanker in Vlaanderen, Leeftijdscategorie Mortaliteit versus incidentie ESR (N/ ) Borstkanker in Vlaanderen, Leeftijdscategorie 70+ Mortaliteit versus incidentie Jaar Incidentie Mortaliteit Jaar Incidentie Mortaliteit Jaar Incidentie Mortaliteit
22 gestandaardiseerd cijfer (1/ inw.) Breast cancer mortality, Flemish Region, years: breast cancer is the most important cause of death Direct Gestandaardiseerde sterfte door borstkanker. Vlaams Gewest. Betrouwbaarheidsintervallen BG ASR OG 46 Linear (ASR) y = -0,7776x + 47,125 R 2 = 0,
23 Flemish Region, breast cancer: 5y relative survival per stage Borstkanker in Vlaanderen: Relatieve overleving per stadium, % 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Maand I II III IV X
24 ESR (Aantallen / ) Breast Cancer, all ages, flemish region: stage distribution Breast Cancer, all ages: stage distribution, % 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Jaar IV III II I
25 ESR (Aantallen / ) Breast Cancer, years, flemish region: stage distribution Breast cancer, years: stage distribution, % 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Jaar IV III II I
26 Europe: 5-year relative survival, Eurocare-4 F. Berrino et al. 2007
27 Europe, breast cancer: 5-year relative survival, Eurocare-4 F. Berrino et al. 2007
28 5 year relative survival, all cancers, TNEH
29 Conclusion Breast Cancer High incidence in Belgium Differences in incidence in the Belgian regions Further investigations! TNM evolution? Mortality decreasing over time Survival data comparable with the European results Up to a cancer registry for Belgium with useful data for health care workers, autorities, research, etc...
30 Thank you! And... Thank you Cancer Registry team!
Cancer in Ireland 2013: Annual report of the National Cancer Registry
Cancer in 2013: Annual report of the National Cancer Registry ABBREVIATIONS Acronyms 95% CI 95% confidence interval APC Annual percentage change ASR Age standardised rate (European standard population)
Prostate cancer statistics
Prostate cancer in Australia The following material has been sourced from the Australian Institute of Health and Welfare Prostate cancer incorporates ICD-10 cancer code C61 (Malignant neoplasm of prostate).
Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore 2009 2013. National Registry of Diseases Office (NRDO)
Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore 2009 2013 National Registry of Diseases Office (NRDO) Released November 3, 2014 Acknowledgement This report was
Statistics fact sheet
Statistics fact sheet Fact sheet last updated January 2015 EXTERNAL VERSION Macmillan Cancer Support Page 1 of 10 Macmillan and statistics Statistics are important to Macmillan because they help us represent
Gen Re Dread Disease Survey 2004-2008 Initial Results
Gen Re Dread Disease Survey 2004-2008 Wolfgang Droste Session Number: MBR8 Joint IACA, IAAHS and PBSS Colloquium in Hong Kong www.actuaries.org/hongkong2012/ Agenda Background of Gen Re s Dread Disease
Number. Source: Vital Records, M CDPH
Epidemiology of Cancer in Department of Public Health Revised April 212 Introduction The general public is very concerned about cancer in the community. Many residents believe that cancer rates are high
Cancer research in the Midland Region the prostate and bowel cancer projects
Cancer research in the Midland Region the prostate and bowel cancer projects Ross Lawrenson Waikato Clinical School University of Auckland MoH/HRC Cancer Research agenda Lung cancer Palliative care Prostate
Section 8» Incidence, Mortality, Survival and Prevalence
Section 8» Incidence, Mortality, Survival and Prevalence 8.1. Description of Statistics Reported This section focuses on the regional distribution of cancer with data derived from the BC Cancer Registry
No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008
COUNCIL OF THE EUROPEAN UNION Brussels, 22 May 2008 9636/08 SAN 87 NOTE from: Committee of Permanent Representatives (Part 1) to: Council No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY,
The Ontario Cancer Registry moves to the 21 st Century
The Ontario Cancer Registry moves to the 21 st Century Rebuilding the OCR Public Health Ontario Grand Rounds Oct. 14, 2014 Diane Nishri, MSc Mary Jane King, MPH, CTR Outline 1. What is the Ontario Cancer
Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.
Proposed PAHO Plan of Action for Cancer Prevention and Control 2008 2015 Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.
Cancer in Wales. People living longer increases the number of new cancer cases
Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales Iechyd Cyhoeddus Cymru Public Health Wales Am y fersiwn Gymraeg ewch i Cancer in Wales A summary report
New Zealand mortality statistics: 1950 to 2010
Contents New Zealand mortality statistics: 1950 to 2010 Purpose 1 Overview of mortality in New Zealand 2 Deaths, raw numbers and age-standardised rates, total population, 1950 to 2010 2 Death rates from
Cancer incidence and mortality in Europe, 2004
Original article Annals of Oncology 16: 481 488, 2005 doi:10.1093/annonc/mdi098 Cancer incidence and mortality in Europe, 2004 P. Boyle* & J. Ferlay International Agency for Research on Cancer, Lyon, France
Cancer Survival in Belgium
B E L G I A N C A N C E R R E G I S T R Y Cancer Survival in Belgium Belgium 24-28 Brussels-Capital Region 24-28 Walloon Region 24-28 Flemish Region 1999-28 Cancer Survival in Belgium Belgium 24-28 Brussels-Capital
Chapter 2: Health in Wales and the United Kingdom
Chapter 2: Health in Wales and the United Kingdom This section uses statistics from a range of sources to compare health outcomes in Wales with the remainder of the United Kingdom. Population trends Annual
UICC World Cancer Congress. Cancer Staging and Quality of Care
UICC World Cancer Congress August 27 30, 2012, Montreal CANCER STAGE: A neglected cornerstone of Cancer Control Cancer Staging and Quality of Care Christian Wittekind Institut für Pathologie UKL 1 Agenda!
Cancer Screening and Early Detection Guidelines
Cancer Screening and Early Detection Guidelines Guillermo Tortolero Luna, MD, PhD Director Cancer Control and Population Sciences Program University of Puerto Rico Comprehensive Cancer Center ASPPR Clinical
The Belgian Asbestos Fund
The Belgian Asbestos Fund Dr. Marc Vandeweerdt Occupational Diseases Fund - Asbestos Fund 22 January 2011 Asbestos: history Asbestos consumption in Europe 1920: 39,276 T 1950: 369,738 T 1975: 1,410,394
The Burden of Cancer in Asia
P F I Z E R F A C T S The Burden of Cancer in Asia Medical Division PG283663 2008 Pfizer Inc. All rights reserved. Printed in USA/December 2008 In 2002, 4.2 million new cancer cases 39% of new cases worldwide
Making trees from paper. Towards transparent care and decision making by guideline based information standards and decision support
Making trees from paper Towards transparent care and decision making by guideline based information standards and decision support Dr. Ir. Xander Verbeek 26-06-2015 Netherlands Comprehensive Cancer Organization
LifeProtect. Cancer Cover. For Intermediary Use Only
LifeProtect Cancer Cover For Intermediary Use Only There are few families in Ireland that have been unaffected by cancer. In fact, 1 in 3 men and 1 in 4 women in Ireland* will suffer from cancer at some
Non-Hodgkin Lymphoma in Queensland An Overview 2012
Non-Hodgkin Lymphoma in Queensland An Overview 2012 Acknowledgements The authors acknowledge and appreciate the work of Queensland Health staff that contribute to and participate in the maintenance of
Final Report Australian Firefighters Health Study. Summary
Final Report Australian Firefighters Health Study Summary School of Public Health & Preventive Medicine Faculty of Medicine, Nursing and Health Sciences December 2014 STUDY TEAM Monash University Principal
The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales
The effect of the introduction of ICD-10 on cancer mortality trends in Anita Brock, Clare Griffiths and Cleo Rooney, Offi ce for INTRODUCTION From January 2001 deaths in have been coded to the Tenth Revision
Index. Registry Report
2013.1-12 Registry Report 01 02 03 06 19 21 22 23 24 25 26 27 28 29 31 34 35 Index Registry Report 02 Registry Report Registry Report 03 04 Registry Report Registry Report 05 06 Registry Report Registry
Butler Memorial Hospital Community Health Needs Assessment 2013
Butler Memorial Hospital Community Health Needs Assessment 2013 Butler County best represents the community that Butler Memorial Hospital serves. Butler Memorial Hospital (BMH) has conducted community
Cost of Cancer in NSW A report by Access Economics Pty Limited for The Cancer Council NSW
Cost of Cancer in NSW A report by Access Economics Pty Limited for Prepared with information available to June 2006 and published in April 2007. TABLE OF CONTENTS Preface... i Acknowledgements and Disclaimer...iii
Radiotherapy in Hungary: present status and future needs. Tibor Major, PhD National Institute of Oncology Radiotherapy Department Budapest, Hungary
Radiotherapy in Hungary: present status and future needs Tibor Major, PhD National Institute of Oncology Radiotherapy Department Budapest, Hungary Academia Europaea Section Workshops, Bergen, 10 September,
Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008
Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008 David R. Risser, M.P.H., Ph.D. [email protected] Epidemiologist Cancer Epidemiology and Surveillance Branch
Cancer in Cumbria Jennifer Clay Public Health Intelligence Analyst November 2008 www.cumbria.nhs.uk
Cancer in Cumbria Jennifer Clay Public Health Intelligence Analyst November 2008 www.cumbria.nhs.uk 2 Table of contents: Summary... 4 Introduction..6 Cancer Incidence 7 Cancer Mortality....13 Cancer Survival
Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008
Special Report Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Matthew B. Schabath, PhD, Zachary J. Thompson, PhD,
The Health and Well-being of the Aboriginal Population in British Columbia
The Health and Well-being of the Aboriginal Population in British Columbia Interim Update February 27 Table of Contents Terminology...1 Health Status of Aboriginal People in BC... 2 Challenges in Vital
THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR)
THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR) Professor Nico van Zandwijk Director Asbestos Diseases Research Institute US US UK UK COUNTRY NZ CAN COUNTRY NZ CAN AUS AUS Mesothelioma International context
Cancer in Primary Care: Prostate Cancer Screening. How and How often? Should we and in which patients?
Cancer in Primary Care: Prostate Cancer Screening How and How often? Should we and in which patients? PLCO trial (Prostate, Lung, Colorectal and Ovarian) Results In the screening group, rates of compliance
How To Know If You Have Cancer At Mercy Regional Medical Center
MERCY REGIONAL CANCER CENTER 2012 CANCER PROGRAM ANNUAL REPORT Using 2011 Data Mercy Regional Cancer Center When you have cancer, you might think first of treatments chemotherapy and radiation. You want
"Belgian Universal Design Education Project (2001-2006)" Universal Design Design for All
Presentation for Bas International Conference, 2006, Brugge: Universal Design of buildings: tools and policy "Belgian Universal Design Education Project (2001-2006)" Universal Design Design for All Hubert
Measures of Prognosis. Sukon Kanchanaraksa, PhD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
Market Update 08 2011
Market Update 8 211 Le travail intérimaire en Belgique Uitzendarbeid in België Temporary Agency Work in Belgium TAW activity slightly slows down in August Monthly Evolution 8/211 7/211.52%.26%.9% [Note
Key Health Areas Mapped to Out of Hospital Programme Areas
1 Key Area (according to letter from David Nicholson) Reducing the number of years of life lost by the people of England from treatable conditions (e.g. including cancer, stroke, heart disease, respiratory
Terminal illness pricing considerations. Steve Varney
pricing considerations Presenters Brad Louis Steve Varney AGENDA 1. Current Status 2. Estimating TI Cost 3. Data and Critical Assumptions 4. Estimated Costs 5. Conclusions 1: CURRENT STATUS Terminal Illness
ST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival
ST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival It is logical that the Cancer Program Committee choose to review the Lung Site, as Lung is the second
SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR.
SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR. TRACEY O CONNOR RESEARCH QUESTON Patients with previously diagnosed hematologic
Decision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced
September 27, 2013 ONO PHARMACEUTICAL CO., LTD. Corporate Communications Phone: +81-6-6263-5670 Decision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced
Critical Illness Products in South Africa
Critical Illness Products in South Africa An overview 1 ICA Cancun 2002 - Critical Ilness Agenda Historical development Trends & recent developments in product design Market statistics 2 ICA Cancun 2002
Patient Access to Cancer Drugs in Nine Countries in the Middle East
Patient Access to Cancer Drugs in Nine Countries in the Middle East Frida Kasteng¹ Nils Wilking² Bengt Jönsson³ ¹i3 Innovus, Stockholm, Sweden ² Karolinska Institutet, Stockholm, Sweden ³ Stockholm School
Table 2.2. Cohort studies of consumption of alcoholic beverages and cancer in special populations
North America Canada Canadian 1951 Schmidt & Popham (1981) 1951 70 9 889 alcoholic men, aged 15 years, admitted to the clinical service of the Addiction Research Foundation of Ontario between Death records
Big Data and Oncology Care Quality Improvement in the United States
Big Data and Oncology Care Quality Improvement in the United States Peter P. Yu, MD, FACP, FASCO President, American Society of Clinical Oncology Director of Cancer Research, Palo Alto Medical Foundation
CONTINUING MEDICAL EDUCATION
ANZ J. Surg. 2004; 74: 931 934 CONTINUING MEDICAL EDUCATION CONTINUING MEDICAL EDUCATION CANCER STATISTICS: EVERYTHING YOU WANTED TO KNOW ABOUT THE CANCER REGISTRY DATA BUT WERE TOO AFRAID TO ASK GRAHAM
Early mortality rate (EMR) in Acute Myeloid Leukemia (AML)
Early mortality rate (EMR) in Acute Myeloid Leukemia (AML) George Yaghmour, MD Hematology Oncology Fellow PGY5 UTHSC/West cancer Center, Memphis, TN May,1st,2015 Off-Label Use Disclosure(s) I do not intend
Chapter I Overview Chapter Contents
Chapter I Overview Chapter Contents Table Number Contents I-1 Estimated New Cancer Cases and Deaths for 2005 I-2 53-Year Trends in US Cancer Death Rates I-3 Summary of Changes in Cancer Incidence and Mortality
Rare Thoracic Tumours
Rare Thoracic Tumours 1. Epithelial Tumour of Trachea 1 1.1 General Results Table 1. Epithelial Tumours of Trachea: Incidence, Trends, Survival Flemish Region 2001-2010 Both Sexes Incidence Trend EAPC
Cancer patients waiting for potentially live-saving treatments in UK
Cancer patients waiting for potentially live-saving treatments in UK 29 May 2005 UK patients are waiting too long for new treatments, according to a 'Dossier of Delay' compiled by information charity CancerBACUP.
C a nc e r C e nter. Annual Registry Report
C a nc e r C e nter Annual Registry Report 214 214 Cancer Registry Report Larraine A. Tooker, CTR Please note that the 214 Cancer Registry Annual Report is created in 214, but it reflects data on cases
Cancer Incidence and Survival By Major Ethnic Group, England, 2002-2006
national cancer intelligence network Cancer Incidence and Survival By Major Ethnic Group, England, 00-006 info.cancerresearchuk.org/cancerstats www.ncin.org.uk Cancer Incidence and Survival By Major Ethnic
Social inequalities impacts of care management and survival in patients with non-hodgkin lymphomas (ISO-LYMPH)
Session 3 : Epidemiology and public health Social inequalities impacts of care management and survival in patients with non-hodgkin lymphomas (ISO-LYMPH) Le Guyader-Peyrou Sandra Bergonie Institut Context:
KINGS COUNTY HOSPITAL CENTER EXECUTIVE SUMMARY. Always Here When You Need Us
KINGS COUNTY HOSPITAL CENTER EXECUTIVE SUMMARY Always Here When You Need Us Kings County Hospital Center Cancer Care Program ANNUAL REPORT 2013: EXECUTIVE SUMMARY The Kings County Hospital Center Cancer
Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data
Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data Prepared for the 138th Annual Meeting of the American Public Health Association Denver, CO
Mužík J., Dušek L., Blaha M., Klika P. Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech republic
Hospital-based data in regional and local strategies optimizing CRC control and management: real-world outcomes of the Czech National Cancer Control Programme Mužík J., Dušek L., Blaha M., Klika P. Institute
INTERNSHIP Tourist Office for Flanders Brussels New York City
INTERNSHIP Tourist Office for Flanders Brussels New York City Who are we? The Tourist Office for Flanders (Belgium) New York Office is a representative office in accordance to the Foreign Agencies Registration
THINGS TO BE AWARE OF ABOUT PROSTATE AND LUNG CANCER. Lawrence Lackey Jr., M.D. Internal Medicine 6001 W. Outer Dr. Ste 114
THINGS TO BE AWARE OF ABOUT PROSTATE AND LUNG CANCER Lawrence Lackey Jr., M.D. Internal Medicine 6001 W. Outer Dr. Ste 114 WHAT IS CANCER? The body is made up of hundreds of millions of living cells. Normal
CHRONIC DISEASE HEALTH PROFILE REGIONS AND COUNTIES: TENNESSEE EAST REGION
CHRONIC DISEASE HEALTH PROFILE REGIONS AND COUNTIES: TENNESSEE EAST REGION TENNESSEE DEPARTMENT OF HEALTH OFFICE OF POLICY, PLANNING & ASSESSMENT SURVEILLANCE, EPIDEMIOLOGY AND EVALUATION DECEMBER 211
Survivorship Care Plans Guides for Living After Cancer Treatment
Survivorship Care Plans Guides for Living After Cancer Treatment Institute of Medicine Report 2005 Recommendations for meeting needs of cancer survivors Implement survivorship care plan Build bridges
Epidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD
Epidemiology, Staging and Treatment of Lung Cancer Mark A. Socinski, MD Associate Professor of Medicine Multidisciplinary Thoracic Oncology Program Lineberger Comprehensive Cancer Center University of
European Parliament resolution on breast cancer in the European Union (2002/2279(INI))
P5_TA(2003)0270 Breast cancer European Parliament resolution on breast cancer in the European Union (2002/2279(INI)) The European Parliament, having regard to Article 152 of the EC Treaty as amended by
Selected Health Status Indicators DALLAS COUNTY. Jointly produced to assist those seeking to improve health care in rural Alabama
Selected Health Status Indicators DALLAS COUNTY Jointly produced to assist those seeking to improve health care in rural Alabama By The Office of Primary Care and Rural Health, Alabama Department of Public
